New York, NY – August 1, 2016 – InvestorsHub NewsWire -- Wall Street Corner Report announces that Puration, Inc. (PURA) is experiencing high trading volume today.  The online analysis firm, Stock Technical Analysis, indicates that current candlestick analysis rates PURA’s potential as very bullish
 
On Thursday last week, July 28, 2016, PURA subtly announced signing a $1 million contract.  The Company released news with a headline about independent test results certifying PURA’s crystal CBD extract at 88% purity and sliding into the content of the press release mention of a $1 million contract that had been recently signed and would be formally announced this week:
 
“The Company has recently executed its first collaboration agreement to produce an infused food and beverage consumer product anticipated to result in $1 million in revenue within the first year of product sales.  The test results announced today are instrumental to the collaboration agreement.  Look for a formal announcement next week introducing the products forthcoming from the collaboration agreement.”
 
The Wall Street Corner Report first learned about PURA in conjunction with its ongoing coverage of North American Cannabis Holdings, Inc. (USMJ).  PURA is a
spinoff of USMJ with a dividend of PURA stock to USMJ shareholders pending.
 


The Wall Street Corner Report considers PURA comparable to an earlier version of  GW Pharmaceuticals (GWPH) in that both are developing commercial applications of cannabis extracts.
 
Wall Street Corner Report anticipates PURA to experience an ‘accumulation phase’ with the shareholder base expanding and diversifying.  As the Company’s news becomes more disseminated throughout the market, Wall Street Corner Report anticipates a rapid PPS increase to as high as $1.00.
 
GWPH has a market cap of $2B - approximately 33 times revenue.  The majority of revenue is non-cash consideration while the company is still largely in a research phase.  If PURA were to achieve a valuation at only 15 times its forecasted $3 million revenue, the PPS would be $0.90.


Learn more about Puration Inc., on the Company’s website:
http://www.purationinc.com/

Wall Street Corner Report is the premier discovery site for promising, yet undiscovered small and micro-cap stocks featuring opportunities in an ethical, professional, and responsible manner. We're not fiendishly 'short' sighted nor are we here to dream the impossibly 'long' dream.  We take a practical view on the big ideas of well-intentioned management and look to profit on each reasonably achievable step the well intentioned mangers take toward their big ideas.

http://www.wallstreetcornerreport.com/

https://twitter.com/WallStCornerRpt

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
 
Jack Taylor
info@wallstreetcornerreport.com

 

GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more GW Pharmaceuticals Charts.
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more GW Pharmaceuticals Charts.